HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Multiple-digit periungual Bowen's disease: a novel treatment approach with radiotherapy.

Abstract
Multiple periungual Bowen disease [BD; also known as squamous cell carcinoma (SCC) in situ] is rare. The pathogenesis of the disease is linked to human papilloma virus, and in some instances to chronic immunosuppression. The usual management of periungual BD is by local excision, Mohs micrographic surgery or distal phalanx amputation. Our patient was offered radiotherapy in the hope of maximizing residual function and minimizing morbidity from treatment. A good response was seen at 2 months post-radiotherapy, but this was followed by relapses at 4 and 6 months post-radiotherapy. Persistent anonychia resulted in improved access to the involved skin, making topical therapy possible. Radiotherapy can be a valuable management approach for periungual SCC/BD in locations where amputation could result in substantial disability.
AuthorsW T Hunt, A Cameron, P Craig, D A de Berker
JournalClinical and experimental dermatology (Clin Exp Dermatol) Vol. 38 Issue 8 Pg. 857-61 (Dec 2013) ISSN: 1365-2230 [Electronic] England
PMID23937119 (Publication Type: Case Reports, Journal Article)
Copyright© 2013 British Association of Dermatologists.
Chemical References
  • Antineoplastic Agents
Topics
  • Adult
  • Antineoplastic Agents (therapeutic use)
  • Bowen's Disease (drug therapy, radiotherapy)
  • Combined Modality Therapy (methods)
  • Humans
  • Male
  • Nail Diseases (drug therapy, radiotherapy)
  • Neoplasm Recurrence, Local
  • Skin Neoplasms (drug therapy, radiotherapy)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: